Aitor Martín-Pintado-Zugasti1, Josué Fernández-Carnero2, Jose Vicente León-Hernández3, Cesar Calvo-Lobo4, Hector Beltran-Alacreu5, Isabel Alguacil-Diego6, Tomás Gallego-Izquierdo7, Daniel Pecos-Martin8. 1. Department of Physical Therapy, Faculty of Medicine, CEU-San Pablo University, Madrid, Spain(∗). 2. Department of Physical Therapy, Occupational Therapy, Rehabilitation and Physical Medicine, Rey Juan Carlos University, Madrid; Research Group on Movement and Behavioural Science and Study of Pain, The Center for Advanced Studies University La Salle, Autónoma University, Madrid; La Paz Hospital Institute for Health Research, IdiPAZ, Madrid; and Grupo Multidisciplinar de Investigación y Tratamiento del Dolor. Grupo de Excelencia Investigadora URJC-Banco de Santander, Rey Juan Carlos University, Madrid, Spain(†). Electronic address: Josue.fernandez@urjc.es. 3. Department of Physiotherapy, Faculty of Health Science, The Center for Advanced Studies University La Salle. Autónoma University, Madrid, Spain(‡). 4. Nursing and Physical Therapy Department, Institute of Biomedicine (IBIOMED), Universidad de León, León, Spain(§). 5. Departamento de Fisioterapia, Centro Superior de Estudios Universitarios La Salle, Universidad Autónoma de Madrid, Madrid; and Motion in Brains Research Group, Institute of Neuroscience and Movement Sciences (INCIMOV), Centro Superior de Estudios Universitarios La Salle, Universidad Autonóma de Madrid, Madrid, Spain(¶). 6. Department of Physical Therapy, Occupational Therapy, Rehabilitation and Physical Medicine. Rey Juan Carlos University, Madrid, Spain(#). 7. Department of Physical Therapy of Alcalá University, Alcalá de Henares, Spain; and Physiotherapy and Pain Group, Alcalá de Henares, Spain(∗∗). 8. Department of Physical Therapy of Alcalá University, Alcalá de Henares, Spain; and Physiotherapy and Pain Group, Alcalá de Henares, Spain(††).
Abstract
BACKGROUND: Previous studies in asymptomatic subjects have demonstrated that myofascial trigger point (MTrP) dry needling frequently is associated with postneedling soreness. However, to the authors' knowledge, there is not any study that performs a detailed description of postneedling soreness characteristics in patients with myofascial pain. This information could help clinicians to make evidence-informed decisions considering the benefits and negative effects of different dry needling dosages. OBJECTIVE: To (1) compare the prevalence, intensity, and duration of postneedling soreness and tenderness after different dosages of deep dry needling (DDN) and (2) analyze the influence on postneedling soreness of psychological factors and other factors involved in the DDN process DESIGN: 1-week follow-up, double-blind randomized controlled trial. SETTING:University community. PARTICIPANTS: Patients (n = 120: 34 male; 86 female) aged 18-53 years (median ± interquartile range, 21.0 ± 7.0 years) with active MTrPs in the upper trapezius. INTERVENTION: All patients received DDN in an active MTrP. They were randomly divided into 4 groups: no local twitch responses (LTRs) elicited (control group), 4 LTRs elicited, 6 LTRs elicited, and DDN until no more LTRs were elicited. MAIN OUTCOME MEASURES: Postneedling soreness and pressure pain threshold were assessed before treatment, during DDN procedure, and every 24 hours during 1 week. RESULTS: Postneedling soreness showed a significant effect for time (F2,006 = 173.603; P < .001, ηp2 = 0.659) and a significant interaction between group and time (F6,017 = 3.763; P = .001; ηp2 = 0.111). Pressure pain threshold showed a significant effect for time (F2,377 = 16.833; P < .001; ηp2 = 0.127) and a significant interaction between group and time (F7,130 = 2.100; P = .04; ηp2 = 0.052). Psychological factors did not show relevant correlations with the intensity of postneedling soreness. CONCLUSIONS: Postneedling soreness is present in most of subjects after DDN of active MTrPs. The groups in which DDN was performed eliciting LTRs exhibited greater post-needling soreness. The number of needle insertions was associated with postneedling soreness but psychological factors did not seem to play a relevant role on its perception. CLINICAL TRIAL REGISTRATION NUMBER: NCT02190890 LEVEL OF EVIDENCE: I.
RCT Entities:
BACKGROUND: Previous studies in asymptomatic subjects have demonstrated that myofascial trigger point (MTrP) dry needling frequently is associated with postneedling soreness. However, to the authors' knowledge, there is not any study that performs a detailed description of postneedling soreness characteristics in patients with myofascial pain. This information could help clinicians to make evidence-informed decisions considering the benefits and negative effects of different dry needling dosages. OBJECTIVE: To (1) compare the prevalence, intensity, and duration of postneedling soreness and tenderness after different dosages of deep dry needling (DDN) and (2) analyze the influence on postneedling soreness of psychological factors and other factors involved in the DDN process DESIGN: 1-week follow-up, double-blind randomized controlled trial. SETTING: University community. PARTICIPANTS: Patients (n = 120: 34 male; 86 female) aged 18-53 years (median ± interquartile range, 21.0 ± 7.0 years) with active MTrPs in the upper trapezius. INTERVENTION: All patients received DDN in an active MTrP. They were randomly divided into 4 groups: no local twitch responses (LTRs) elicited (control group), 4 LTRs elicited, 6 LTRs elicited, and DDN until no more LTRs were elicited. MAIN OUTCOME MEASURES: Postneedling soreness and pressure pain threshold were assessed before treatment, during DDN procedure, and every 24 hours during 1 week. RESULTS: Postneedling soreness showed a significant effect for time (F2,006 = 173.603; P < .001, ηp2 = 0.659) and a significant interaction between group and time (F6,017 = 3.763; P = .001; ηp2 = 0.111). Pressure pain threshold showed a significant effect for time (F2,377 = 16.833; P < .001; ηp2 = 0.127) and a significant interaction between group and time (F7,130 = 2.100; P = .04; ηp2 = 0.052). Psychological factors did not show relevant correlations with the intensity of postneedling soreness. CONCLUSIONS: Postneedling soreness is present in most of subjects after DDN of active MTrPs. The groups in which DDN was performed eliciting LTRs exhibited greater post-needling soreness. The number of needle insertions was associated with postneedling soreness but psychological factors did not seem to play a relevant role on its perception. CLINICAL TRIAL REGISTRATION NUMBER: NCT02190890 LEVEL OF EVIDENCE: I.
Authors: Eleuterio A Sánchez Romero; Tifanny Lim; Jorge Hugo Villafañe; Gurvan Boutin; Victor Riquelme Aguado; Aitor Martin Pintado-Zugasti; José Luis Alonso Pérez; Josué Fernández Carnero Journal: Int J Environ Res Public Health Date: 2021-04-15 Impact factor: 3.390
Authors: Nicola Sante Diciolla; Celia Pérez-Clemente; Marta Cámara-Caballero; Alberto Matienzo-Barreto; Alba Real-Rodríguez; María Torres-Lacomba Journal: J Clin Med Date: 2021-11-25 Impact factor: 4.241
Authors: Luis Martín-Sacristán; Cesar Calvo-Lobo; Daniel Pecos-Martín; Josué Fernández-Carnero; José Luis Alonso-Pérez Journal: Sci Rep Date: 2022-02-24 Impact factor: 4.379